Testing seizure medicines after a first seizure in brain tumors
Treatments studied
Part of Cancer clinical trials.
This trial studies which seizure medicine works best for adults who recently had their first seizure caused by certain brain tumors. It may help reduce seizures and improve daily functioning while choosing the right medicine after the first episode.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have a brain tumor diagnosis such as glioblastoma or diffuse glioma, with specific genetic types (IDH status and sometimes 1p/19q codeletion)
- Your first seizure happened within the last 2 weeks
- At the time of enrollment, doctors think you should take only one seizure medicine (not multiple)
- You can sign a consent form in writing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving levetiracetam (a seizure-preventing medicine) before and after surgery to remove a brain tumor can reduce the chance of having seizures. It may help patients who have never had a seizure before.
This trial tests whether adding an extended-release seizure medication (levetiracetam) to standard treatment helps people with a certain type of glioblastoma. It may improve outcomes by targeting tumors with low oxygen levels.
This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.
This study tests whether giving a seizure medication (levetiracetam) to people with brain tumors in the movement area can prevent seizures. It compares taking the medication to not taking it, starting before any seizure occurs.
This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.
This study compares stopping seizure medicine (levetiracetam) after 6 months versus continuing it longer for people with primary brain tumors. It aims to find out if it is safe to stop the medication sooner and may help you avoid long-term side effects.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.